How fast do childhood cancers grow — and why it matters right now

Leukaemia is the most common childhood cancer, and it arises in the bone marrow — the factory that makes blood cells. When leukaemia starts, abnormal white blood cells begin multiplying and crowding out normal red blood cells, platelets, and healthy white cells. In Acute Lymphoblastic Leukaemia (ALL) — the most common type — a child can go from having only mild tiredness and paleness to a critically low blood count, easy bruising, unexplained fever, and bone pain within one to four weeks. In Acute Myeloid Leukaemia (AML), the deterioration can happen even faster. The reason is biological: leukaemia cells do not need to form a solid mass before causing harm — they circulate in the blood and begin impairing normal blood cell function very early. A simple blood test (complete blood count) will usually show the abnormality. If your child has been persistently pale, tired, and getting repeated infections or unexplained bruising, do not wait more than a week to get a blood test done.

Burkitt lymphoma deserves special mention because it is one of the fastest-growing human cancers known to medicine. Its tumour doubling time — the time it takes for the tumour to double in size — is measured in hours to a couple of days, rather than the weeks or months typical of most cancers. A child with Burkitt lymphoma can develop a visible abdominal mass, facial swelling, or markedly enlarged lymph nodes over the course of just a few days to a week. This is a medical emergency, and it requires same-day or next-day evaluation at a cancer centre with experience in paediatric lymphoma. Hodgkin lymphoma, by contrast, is typically much slower — it often presents as a rubbery, painless node in the neck that grows gradually over weeks to months and responds very well to treatment even at later stages. Knowing which lymphoma type a child may have makes a significant difference to how urgently the family needs to act.

Brain tumours are the most common solid tumours in children, and their growth speed ranges more widely than almost any other cancer group. A pilocytic astrocytoma (a low-grade tumour of the cerebellum or optic pathway) may grow so slowly that symptoms build over months to years before a parent notices something has changed. At the other end of the spectrum, Diffuse Intrinsic Pontine Glioma (DIPG) — a tumour in the brainstem — is one of the most aggressive paediatric cancers known. DIPG can cause rapid loss of cranial nerve function, balance problems, and facial drooping over a period of days to weeks. The location of a brain tumour matters as much as its grade: even a slow-growing tumour that sits on the optic nerve or near the cerebral aqueduct can cause significant harm early on simply because of what it is pressing against. Warning signs such as persistent morning headache with vomiting, double vision, a newly developing squint, or worsening balance in a child should never be attributed to stress or fatigue without proper imaging.

Neuroblastoma is the most common solid cancer in infants under one year of age, arising from immature nerve cells typically in the adrenal glands (above the kidneys) or along the spinal cord. What makes neuroblastoma unusual is that its behaviour varies more dramatically by risk group than almost any other childhood cancer. Low-risk neuroblastoma — often found in infants — can sometimes spontaneously shrink and even disappear without treatment; these tumours grow slowly. Intermediate-risk neuroblastoma grows steadily over weeks to months and is treated with a planned course of chemotherapy. High-risk neuroblastoma, however, is one of the most aggressive solid tumours in childhood — it can spread to the bone marrow, liver, skin, and lymph nodes before the primary tumour in the abdomen has been large enough to cause obvious symptoms. High-risk neuroblastoma requires intensive treatment at an experienced oncology centre. A firm abdominal mass in a child under five, especially on one side, should be assessed by ultrasound within days.

Wilms tumour (nephroblastoma) is the most common kidney cancer in children, typically affecting children between the ages of 3 and 4. It grows within the kidney over a period of weeks to months before it becomes large enough to feel or cause symptoms. In most cases, it does not cause pain — the first sign is often a smooth, firm swelling felt on one side of the abdomen when a parent is bathing or dressing the child, or found by a doctor during a routine check. Because Wilms tumour grows steadily but not explosively, there is usually a reasonable window between when it could first be detected and when it begins to spread — but that window should be used, not waited through. Wilms tumour responds very well to treatment, particularly when found before it has spread beyond the kidney. Do not delay an abdominal ultrasound if a lump is felt in a child under 8 years old.

Osteosarcoma and Ewing sarcoma are the two most common bone cancers in children and teenagers, and both tend to peak in the adolescent years during the rapid growth spurt of puberty. They typically begin as a dull, aching pain in a limb — most commonly around the knee, the upper arm near the shoulder, or the pelvis — that is easily mistaken for growing pains or a sports injury. Over a period of weeks to months, the pain usually worsens, and a visible or palpable swelling may develop at the site. The critical concern with bone cancers is not just their primary growth but their tendency to spread to the lungs relatively early — making timely diagnosis important. A teenager with persistent bone pain that has lasted more than three to four weeks, is worse at night, is not related to any injury, and is located in a long bone should have an X-ray followed by MRI if the X-ray raises any concern. These symptoms should not simply be attributed to sports or growth without imaging to confirm.